BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11768128)

  • 1. Effects of exogenous recombinant interleukin-12 on immune responses and protection against Brucella abortus in a murine model.
    Lee IK; Olsen SC; Bolin CA
    Can J Vet Res; 2001 Oct; 65(4):223-8. PubMed ID: 11768128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adjuvant effect of a single dose of interleukin-12 on murine immune responses to live or killed Brucella abortus strain RB51.
    Lee IK; Olsen SC; Kehrli M; Bolin CA
    Can J Vet Res; 1999 Oct; 63(4):284-7. PubMed ID: 10534009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses and efficacy after administration of a commercial Brucella abortus strain RB51 vaccine to cattle.
    Olsen SC
    Vet Ther; 2000; 1(3):183-91. PubMed ID: 19757581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An aerosolized Brucella spp. challenge model for laboratory animals.
    Olsen SC; Waters WR; Stoffregen WS
    Zoonoses Public Health; 2007; 54(8):281-5. PubMed ID: 17894637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses and resistance to brucellosis in mice vaccinated orally with Brucella abortus RB51.
    Stevens MG; Olsen SC; Palmer MV; Pugh GW
    Infect Immun; 1996 Nov; 64(11):4534-41. PubMed ID: 8890203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of cattle to two dosages of Brucella abortus strain RB51: serology, clearance and efficacy.
    Olsen SC; Bricker B; Palmer MV; Jensen AE; Cheville NF
    Res Vet Sci; 1999 Apr; 66(2):101-5. PubMed ID: 10208887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of immune responses and resistance to brucellosis in mice vaccinated with Brucella abortus 19 or RB51.
    Stevens MG; Olsen SC; Pugh GW; Brees D
    Infect Immun; 1995 Jan; 63(1):264-70. PubMed ID: 7806364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses of elk to initial and booster vaccinations with Brucella abortus strain RB51 or 19.
    Olsen SC; Fach SJ; Palmer MV; Sacco RE; Stoffregen WC; Waters WR
    Clin Vaccine Immunol; 2006 Oct; 13(10):1098-103. PubMed ID: 17028213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of adult cattle to vaccination with a reduced dose of Brucella abortus strain RB51.
    Olsen SC
    Res Vet Sci; 2000 Oct; 69(2):135-40. PubMed ID: 11020364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic responses of bison to vaccination with Brucella abortus strain RB51: comparison of parenteral to ballistic delivery via compressed pellets or photopolymerized hydrogels.
    Olsen SC; Christie RJ; Grainger DW; Stoffregen WS
    Vaccine; 2006 Feb; 24(9):1346-53. PubMed ID: 16236400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of calfhood vaccination with Brucella abortus strain RB51 in protecting bison against brucellosis.
    Olsen SC; Jensen AE; Stoffregen WC; Palmer MV
    Res Vet Sci; 2003 Feb; 74(1):17-22. PubMed ID: 12507562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses of bison to ballistic or hand vaccination with Brucella abortus strain RB51.
    Olsen SC; Kreeger TJ; Schultz W
    J Wildl Dis; 2002 Oct; 38(4):738-45. PubMed ID: 12528440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle.
    Wyckoff JH; Howland JL; Scott CM; Smith RA; Confer AW
    Vet Microbiol; 2005 Nov; 111(1-2):77-87. PubMed ID: 16242273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of Brucella abortus strain RB51 in black bears.
    Olsen SC; Rhyan J; Gidlewski T; Goff J; Stoffregen WC
    J Wildl Dis; 2004 Jul; 40(3):429-33. PubMed ID: 15465709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental infection of nontarget species of rodents and birds with Brucella abortus strain RB51 vaccine.
    Januszewski MC; Olsen SC; McLean RG; Clark L; Rhyan JC
    J Wildl Dis; 2001 Jul; 37(3):532-7. PubMed ID: 11504226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of Brucella abortus strain RB51 lyophilized and as liquid vaccine under different storage conditions.
    Capsel RL; Olsen SC; Cheville NF; Thoen CO
    Biologicals; 2000 Dec; 28(4):209-15. PubMed ID: 11237356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral or intravenous inoculation with Brucella abortus strain RB51 vaccine in beagles.
    Palmer MV; Cheville NF
    Am J Vet Res; 1997 Aug; 58(8):851-6. PubMed ID: 9256969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monophosphoryl lipid A-induced immune enhancement of Brucella abortus salt-extractable protein and lipopolysaccharide vaccines in BALB/c mice.
    Tabatabai LB; Pugh GW; Stevens MG; Phillips M; McDonald TJ
    Am J Vet Res; 1992 Oct; 53(10):1900-7. PubMed ID: 1456539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.